Insider Cluster (2 insiders) ·Filed Aug 26, 2026

UTHR

UNITED THERAPEUTICS Corp
NEUTRAL
Impact 3/10
Horizonimmediate Processed1mo ago
Insider cluster: 2 insiders, $1.1M total
Actionable Insight • Neutral

The CEO's sales are routine cashless exercise-and-sell transactions — not a bearish signal. Monitor for any unexpected insider buying or material corporate events (earnings, pipeline updates) that could shift the narrative. No immediate trading action warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+20d ⚠ clustered
UTHR ▼ -4.56% at T+20d
NEUTRAL call ✗ call lost -4.56% · α vs SPY -5.77% · entry $516.68 → $493.10
Next anchor: T+60d in 7w
Latest observation: T+23 -5.01% FF3 residual α
Entry anchored
Aug 25, 04:20 PM ET
via 1-min bar
T+1d
+2.17%
call +2.17% · α +1.52%
$527.91
settled 5w ago
T+5d
-4.77%
call -4.77% · α -4.65%
$492.02
settled 4w ago
T+20d
-4.56%
call -4.56% · α -5.77%
$493.10
settled 9d ago
T+60d
—
call — · α —
—
in 7w

Price Chart

Loading chart...

Executive Summary

CEO Martine Rothblatt executed a large cluster of open-market sales totaling approximately $12.5M over Aug 21-25, alongside derivative exercises. EVP Paul Mahon sold $101K. The CEO's sales represent about 0.06% of UTHR's $22.2B market cap, falling below the 0.1% materiality threshold for insider sales. Per academic literature, insider sales are weak predictors and this cluster is likely liquidity-driven following option exercises, not a bearish signal. The filing is routine and neutral.

Key Financial Metrics

Direction
selling
Total Value
$12.6M
Insiders
2

Key Facts

  • CEO Martine Rothblatt sold ~$12.5M in open-market shares over Aug 21-25, 2026, following derivative exercises at $135.42/share and $0.
  • EVP & General Counsel Paul Mahon sold 192 shares for ~$101K on Aug 20, 2026.
  • Total open-market sales of ~$12.6M represent ~0.06% of UTHR's $22.2B market cap — below the 0.1% materiality threshold.
  • All CEO sales were preceded by same-day derivative exercises, consistent with a cashless exercise-and-sell pattern for tax/expense purposes.
  • No other insiders (directors, officers) reported open-market purchases in the cluster window.

Financial Impact

CEO sold ~$12.5M in shares, representing 0.06% of market cap — immaterial relative to company size.

dilution

Risk Factors

  • CEO selling pattern could be misinterpreted by the market as a negative signal despite being routine.
  • No insider buying to offset the selling — continued absence of insider purchases could indicate lack of conviction at current valuation.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
82% bullish (22 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-UTHR-1787810509446
91 reports for UTHR
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+60▲ +5.53%Feb 25, 2026
Filters
Rows
Reports for UTHR — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
NEUTRAL ★ 2/10
$500.35 $497.31▼ −0.61%▼ −2.72%$571.38 (+14.20%)
Sep 11, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$497.11 $494.63▼ −0.50%▼ −0.28%$571.38 (+14.94%)
Sep 10, 2026
22d ago
Insider Cluster
MIXED ★ 4/10
$503.86 $497.27▼ −1.31%▼ −0.81%$571.38 (+13.40%)
Sep 9, 2026
23d ago
Insider Cluster
NEUTRAL ★ 3/10
$506.82 $498.48▼ −1.65%▼ −0.99%$571.38 (+12.74%)
Sep 4, 2026
28d ago
Insider Cluster
NEUTRAL ★ 2/10
$487.61 $502.70▲ +3.09%▲ +4.30%$571.38 (+17.18%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$488.16 $497.11▲ +1.83%▲ +2.98%$571.38 (+17.05%)
Aug 28, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$515.46 $487.61▼ −5.40%▼ −5.51%$571.38 (+10.85%)
Aug 27, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$527.91 $492.02▼ −6.80%▼ −6.03%$571.38 (+8.23%)
Aug 26, 2026
5w ago
Insider Cluster
NEUTRAL ★ 3/10
$516.68 $492.02▼ −4.77%▼ −4.65%$571.38 (+10.59%)
Aug 25, 2026
5w ago
Insider Cluster
NEUTRAL ★ 2/10
$516.68 $492.02▼ −4.77%▼ −4.65%$571.38 (+10.59%)
Showing 10 of 91

US Market Status

Market Open — Closes in 6h 27m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Aug 27, 2026